Skip to main
JNJ

JNJ Stock Forecast & Price Target

JNJ Analyst Ratings

Based on 19 analyst ratings
Buy
Strong Buy 32%
Buy 32%
Hold 37%
Sell 0%
Strong Sell 0%

Bulls say

Johnson & Johnson is expected to continue its positive growth trajectory driven by investments in new products and a focus on diversity and sustainability, offsetting potential risks such as biosimilar competition and patent expirations. The recent divestment of the consumer business and planned separation of a lower-growth division in 2027 also show the company's commitment to driving value for stakeholders.

Bears say

Johnson & Johnson is facing challenges in their drug division due to loss of exclusivity for certain drugs and potential slow uptake of new pipeline products. In their MedTech division, increased competition and M&A integration disruptions could limit growth potential. Furthermore, litigation and settlement costs could negatively impact profits. Despite strong sustainability initiatives and potential growth in the vision segment, the overall uncertainty surrounding the company's financials leads to a negative outlook on their stock.

JNJ has been analyzed by 19 analysts, with a consensus rating of Buy. 32% of analysts recommend a Strong Buy, 32% recommend Buy, 37% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Johnson & Johnson and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Johnson & Johnson (JNJ) Forecast

Analysts have given JNJ a Buy based on their latest research and market trends.

According to 19 analysts, JNJ has a Buy consensus rating as of Jun 3, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $244.53, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $244.53, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Johnson & Johnson (JNJ)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.